Illumina Closes $400M Note Sale After Adding $50M Over-Allotment
Illumina last week said it has closed the sale of $400 million in convertible senior notes.
The company initially said Feb. 12 it would sell $325 million in notes to pay for corporate expenses, but on Feb. 13 it raised the offering to $350 million (see BAN 2/13/2007).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.